FI107359B - Menetelmä anti-RNA-vasta-aineiden toteamiseksi - Google Patents

Menetelmä anti-RNA-vasta-aineiden toteamiseksi Download PDF

Info

Publication number
FI107359B
FI107359B FI933291A FI933291A FI107359B FI 107359 B FI107359 B FI 107359B FI 933291 A FI933291 A FI 933291A FI 933291 A FI933291 A FI 933291A FI 107359 B FI107359 B FI 107359B
Authority
FI
Finland
Prior art keywords
rna
antibodies
disease
test fluid
sera
Prior art date
Application number
FI933291A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI933291A (fi
FI933291A0 (fi
Inventor
Venrooij Walther Jacobus Van
Rene Antonius Hoet
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI933291A0 publication Critical patent/FI933291A0/fi
Publication of FI933291A publication Critical patent/FI933291A/fi
Application granted granted Critical
Publication of FI107359B publication Critical patent/FI107359B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI933291A 1991-01-22 1993-07-21 Menetelmä anti-RNA-vasta-aineiden toteamiseksi FI107359B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP91200121 1991-01-22
EP91200121 1991-01-22
PCT/EP1992/000106 WO1992013276A1 (en) 1991-01-22 1992-01-16 Method for detection of anti-rna-antibodies
EP9200106 1992-01-16

Publications (3)

Publication Number Publication Date
FI933291A0 FI933291A0 (fi) 1993-07-21
FI933291A FI933291A (fi) 1993-08-18
FI107359B true FI107359B (fi) 2001-07-13

Family

ID=8207502

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933291A FI107359B (fi) 1991-01-22 1993-07-21 Menetelmä anti-RNA-vasta-aineiden toteamiseksi

Country Status (15)

Country Link
US (1) US5385824A (de)
EP (1) EP0568554B1 (de)
JP (1) JP3288041B2 (de)
KR (1) KR100244799B1 (de)
AT (1) ATE126599T1 (de)
AU (1) AU658860B2 (de)
CA (1) CA2101166C (de)
DE (1) DE69204157T2 (de)
DK (1) DK0568554T3 (de)
ES (1) ES2078733T3 (de)
FI (1) FI107359B (de)
GR (1) GR3017975T3 (de)
IE (1) IE66750B1 (de)
WO (1) WO1992013276A1 (de)
ZA (1) ZA92389B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576186A (en) * 1994-09-01 1996-11-19 The University Of Kansas Diagnosis and monitoring of rheumatological diseases by detection of anti-EF1-α antibodies
EP1334113A4 (de) * 2000-10-20 2007-08-08 Expression Diagnostics Inc Erstellen von leukozytenexpressionsprofilen
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7892745B2 (en) * 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
WO2006029184A2 (en) * 2004-09-08 2006-03-16 Expression Diagnostics, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
WO2006122295A2 (en) * 2005-05-11 2006-11-16 Expression Diagnostics, Inc. Methods of monitoring functional status of transplants using gene panels
CA2648580A1 (en) * 2006-04-07 2008-05-02 Xdx, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
US7993832B2 (en) * 2006-08-14 2011-08-09 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
WO2008140484A2 (en) * 2006-11-09 2008-11-20 Xdx, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
WO2012068107A2 (en) * 2010-11-17 2012-05-24 University Of Florida Research Foundation, Inc. Autoantibody to rna-protein complex detected by quantitative pcr
WO2015164635A2 (en) * 2014-04-24 2015-10-29 Alnylam Pharmaceuticals, Inc. Methods and compositions for detecting anti-drug antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784942A (en) * 1984-11-05 1988-11-15 The Board Of Regents For The University Of Oklahoma Monoclonal antibodies against autoimmune RNA proteins
WO1990010229A1 (en) * 1989-02-27 1990-09-07 Biostar Medical Products, Inc. Method and diagnostic test kit for detection of autoimmune antibody

Also Published As

Publication number Publication date
EP0568554A1 (de) 1993-11-10
DK0568554T3 (da) 1995-12-04
AU1161592A (en) 1992-08-27
DE69204157T2 (de) 1996-03-21
KR930703612A (ko) 1993-11-30
IE920132A1 (en) 1992-07-29
WO1992013276A1 (en) 1992-08-06
CA2101166C (en) 2003-05-20
EP0568554B1 (de) 1995-08-16
FI933291A (fi) 1993-08-18
ATE126599T1 (de) 1995-09-15
ES2078733T3 (es) 1995-12-16
JPH06504620A (ja) 1994-05-26
US5385824A (en) 1995-01-31
GR3017975T3 (en) 1996-02-29
IE66750B1 (en) 1996-02-07
JP3288041B2 (ja) 2002-06-04
DE69204157D1 (de) 1995-09-21
AU658860B2 (en) 1995-05-04
FI933291A0 (fi) 1993-07-21
CA2101166A1 (en) 1992-07-23
ZA92389B (en) 1992-09-30
KR100244799B1 (ko) 2000-03-02

Similar Documents

Publication Publication Date Title
JP3786970B2 (ja) オリゴヌクレオチド抗体複合体による抗原の検出
FI107359B (fi) Menetelmä anti-RNA-vasta-aineiden toteamiseksi
JP2002532686A (ja) 癌検出法および試薬
JP2013513107A (ja) 自己抗体抗原結合を阻害するためのペプチド試薬及び方法
US5288614A (en) Method for the detection of malignant diseases
US5340720A (en) Methods of diagnosing and monitoring rheumatic diseases
US10191048B2 (en) Fluorometric immunoassay for detection of anti-dsDNA antibodies
US7189516B2 (en) Method for characterizing autoimmune disorders
WO2001073437A2 (en) Antigen-specific enzyme-linked immunosorbent assay
FI100276B (fi) Menetelmä analyyttien ei-kilpailevaa määritystä varten
CA2662012A1 (en) Boris isoforms and methods of detecting and treating disease
Olaussen et al. Screening tests for antinuclear antibodies (ANA): selective use of central nuclear antigens as a rational basis for screening by ELISA
Synkowski et al. Lupus erythematosus: laboratory testing and clinical subsets in the evaluation of patients
Agnello Immune complex assays in rheumatic diseases
IE55317B1 (en) Diagnostic test for rheumatological diseases
US10234455B2 (en) Regulatory brain specific ctyoplasmic RNAs (BC RNAs) and methods of use thereof in diagnosis and treatment of neuropsychiatric lupus
JP2509840B2 (ja) 免疫測定法及び免疫測定用試薬キット
Class et al. Patent application title: REGULATORY BRAIN SPECIFIC CTYOPLASMIC RNAS (BC RNAs) AND METHODS OF USE THEREOF IN DIAGNOSIS AND TREATMENT OF NEUROPSYCHIATRIC LUPUS
US20050158812A1 (en) Kits and methods for autoantibody detection
JP2009139302A (ja) 癌の検出法
Tran et al. Detection of Anti‐DNA Antibodies
JPH0875739A (ja) モノクローナル抗体を用いたメタンフェタミン測定用イムノセンサー

Legal Events

Date Code Title Description
MM Patent lapsed